Back

Prevalence and predictors of normotensive cardiogenic shock in intermediate-high risk pulmonary embolism.

13 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 1 Pulmonary Embolism (PE) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Barbara Lacerda Teixeira

Hospital de Santa Marta, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail
Relationship between dynamics of cardiac sympathetic innervation, assessed with 123I-MIBG SPECT, exercise capacity and left ventricular reverse remodelling in dilated cardiomyopathy
Doctor E. Dziewiecka (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
The genetic architecture of dilated cardiomyopathy in Hungary: analysis of 135 patients with a panel of 98 genes
Doctor H. Takacs (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Hyponatremia as a predictor of short-term mortality in patients with pulmonary embolism
Doctor J. Gouveia Fiuza (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
PERFORM score: a predictive prognostic tool for anticipating the requirement for fibrinolysis in pulmonary embolism
Doctor M. Duarte Almeida (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
Short and long-term mortality in patients with acute pulmonary embolism: focus on cancer-related disease.
Doctor I. Santos (Ponta Delgada, PT) Doctor F. Duarte (Ponta Delgada, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease - clinical 1

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Risk stratification of intermediate risk pulmonary embolism: importance of normotensive shock
thumbnail
Congress Presentation
Pitfalls of diagnosing high risk pulmonary embolism in the acute setting
thumbnail
Congress Presentation
Selecting the right patient at the right time: predictors and early decision-making in acute pulmonary embolism

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources